Lamees Hegazy
Lamees Hegazy
Center for Clinical Pharmacology
Verified email at stlcop.edu - Homepage
Title
Cited by
Cited by
Year
A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells
H Ikeuchi, YM Ahn, T Otokawa, B Watanabe, L Hegazy, J Hiratake, ...
Bioorganic & medicinal chemistry 20 (19), 5915-5927, 2012
382012
Synthesis, Anti‐B reast Cancer Activity, and Molecular Modeling of Some Benzothiazole and Benzoxazole Derivatives
MA Abdelgawad, A Belal, HA Omar, L Hegazy, ME Rateb
Archiv der Pharmazie 346 (7), 534-541, 2013
302013
Recent Advances in the Medicinal Chemistry of Liver X Receptors: Miniperspective
BEDM El-Gendy, SS Goher, LS Hegazy, MMH Arief, TP Burris
Journal of medicinal chemistry 61 (24), 10935-10956, 2018
152018
Synthesis and DFT studies of an antitumor active spiro-oxindole
AS Girgis, AF Mabied, J Stawinski, L Hegazy, RF George, H Farag, ...
New Journal of Chemistry 39 (10), 8017-8027, 2015
152015
Development of novel liver X receptor modulators based on a 1, 2, 4-triazole scaffold
SS Goher, K Griffett, L Hegazy, M Elagawany, MMH Arief, A Avdagic, ...
Bioorganic & medicinal chemistry letters 29 (3), 449-453, 2019
52019
Complement component 3: characterization and association with mastitis resistance in Egyptian water buffalo and cattle
N El-Halawany, AS Abd-el-monsif, AFM Al-Tohamy, L Hegazy, ...
Journal of genetics 96 (1), 65-73, 2017
42017
The larvicidal activity of natural inspired piperine-based dienehydrazides against Culex pipiens
AH Tantawy, SM Farag, L Hegazy, H Jiang, MQ Wang
Bioorganic Chemistry 94, 103464, 2020
32020
Optimized CGenFF force-field parameters for acylphosphate and N-phosphonosulfonimidoyl functional groups
L Hegazy, NGJ Richards
Journal of molecular modeling 19 (11), 5075-5087, 2013
22013
The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural Retinoids
K Griffett, G Bedia-Diaz, L Hegazy, IMS de Vera, US Wanninayake, ...
Cell Chemical Biology 27 (10), 1272-1284. e4, 2020
12020
Design, Synthesis, and Pharmacological Evaluation of Novel and Selective COX-2 Inhibitors Based on Bumetanide Scaffold
TS Ibrahim, IM Salem, SM Mostafa, OI El-Sabbagh, MKM ElKhamisi, ...
Bioorganic Chemistry, 103878, 2020
12020
Catalyst-and organic solvent-free synthesis, structural, and theoretical studies of 1-arylidenamino-2, 4-disubstituted-2-imidazoline-5-ones
W Saaed, M Elagawany, MM Azab, AS Amin, NP Rath, L Hegazy, ...
Results in Chemistry, 100042, 2020
12020
Catalyst-and organic solvent-free synthesis of thioacids in water
M Elagawany, L Hegazy, B Elgendy
Tetrahedron Letters 60 (30), 2018-2021, 2019
12019
Molecular dynamics simulations and virtual screening to identify potent inhibitors of human asparagine synthetase
L Hegazy
University of Florida, 2013
12013
Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonists
M Shahien, M Elagawany, S Sitaula, SS Goher, SL Burris, R Sanders, ...
Bioorganic Chemistry 102, 104079, 2020
2020
Accelerated molecular dynamics samples slow conformational changes in apo REV-ERB alpha
L Hegazy
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019
2019
Molecular dynamics simulations reveal the mechanism of agonist ligand binding to ERR alpha
L Hegazy
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019
2019
Identification of 4-isopropyl–thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characterization, and biological evaluation
M Elagawany, L Hegazy, F Cao, MJ Donlin, N Rath, J Tavis, B Elgendy
RSC advances 8 (52), 29967-29975, 2018
2018
Structure-based discovery of human asparagine synthetase inhibitors
LS Hegazy, NGJ Richards
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 246, 2013
2013
CHARMM Force Field Parameter Development for Thioester and Acyl-phosphate Functional Groups
L Hegazy, N Richards
Complement component 3: Characterisation and association with mastitis resistance in Egyptian water
N El-Halawany, AS Abd-El-Monsif, AFM Al-Tohamy, L Hegazy, ...
The system can't perform the operation now. Try again later.
Articles 1–20